Cargando…

Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy

Vascular contributions to cognitive impairment and dementia (VCID) are a common cause of cognitive decline, yet limited therapies exist. This cerebrovascular disease results in neurodegeneration via acute, chronic, local, and systemic mechanisms. The etiology of VCID is complex, with a significant i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duong, Michael Tran, Nasrallah, Ilya M., Wolk, David A., Chang, Catherine C. Y., Chang, Ta-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026881/ https://www.ncbi.nlm.nih.gov/pubmed/33841127 http://dx.doi.org/10.3389/fnagi.2021.647990

Ejemplares similares

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
por: Alber, Jessica, et al.
Publicado: (2019)

Retinal biomarkers for Alzheimer’s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis
por: Czakó, Cecilia, et al.
Publicado: (2020)

Chronic Remote Ischemic Conditioning Is Cerebroprotective and Induces Vascular Remodeling in a VCID Model
por: Khan, Mohammad Badruzzaman, et al.
Publicado: (2017)

Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
por: Jann, Kay, et al.
Publicado: (2021)

MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium
por: Maillard, Pauline, et al.
Publicado: (2022)

Sex differences in the effects of high fat diet on underlying neuropathology in a mouse model of VCID
por: Abi-Ghanem, Charly, et al.
Publicado: (2023)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia
por: Price, Brittani R., et al.
Publicado: (2018)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia
por: Linh, Tran Thanh Duy, et al.
Publicado: (2022)

White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia
por: Liu, Qing, et al.
Publicado: (2017)

Arterial spin labeling versus (18)F-FDG-PET to identify mild cognitive impairment
por: Dolui, Sudipto, et al.
Publicado: (2019)

LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea
por: Flores, Rhonda, et al.
Publicado: (2019)

Instrumental validation of free water, peak‐width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits
por: Maillard, Pauline, et al.
Publicado: (2022)

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
por: Shabir, Osman, et al.
Publicado: (2018)

Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia
por: Gustavsson, Anna‐Märta, et al.
Publicado: (2019)

Atherosclerosis: The Culprit and Co-victim of Vascular Dementia
por: Huang, Ya-Ting, et al.
Publicado: (2021)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
por: Vellone, Daniella, et al.
Publicado: (2022)

Saringosterol from Sargassum fusiforme Modulates Cholesterol Metabolism and Alleviates Atherosclerosis in ApoE-Deficient Mice
por: Yan, Ying, et al.
Publicado: (2021)

Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia
por: Gannon, Olivia J., et al.
Publicado: (2023)

Lifestyle Complexity and Dementia Risk: Examining Moderation by APOE Genotype and Mild Cognitive Impairment
por: Moored, Kyle, et al.
Publicado: (2020)

A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia
por: Simonetto, Marialaura, et al.
Publicado: (2019)

Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study
por: Llewellyn, David J, et al.
Publicado: (2010)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels
por: Jun, Ji Eun, et al.
Publicado: (2018)

Puerarin Alleviates Vascular Cognitive Impairment in Vascular Dementia Rats
por: Zhu, Tiantian, et al.
Publicado: (2021)

Stroke injury, cognitive impairment and vascular dementia()
por: Kalaria, Raj N., et al.
Publicado: (2016)

Potential Therapeutics for Vascular Cognitive Impairment and Dementia
por: Sun, Miao-Kun
Publicado: (2018)

Vascular contributions to cognitive impairment and dementia: Research consortia that focus on etiology and treatable targets to lessen the burden of dementia worldwide
por: Gladman, Jordan T., et al.
Publicado: (2019)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia
por: Hoyer-Kimura, Christina, et al.
Publicado: (2021)

Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia
por: Poliakova, Tetiana, et al.
Publicado: (2023)

Identification of the atherosclerosis phenotype in vivo by vascular duplex ultrasonography in ApoE-deficient dogs
por: Jia, Lingyun, et al.
Publicado: (2021)

High ApoB/ApoA-I Ratio Predicts Post-Stroke Cognitive Impairment in Acute Ischemic Stroke Patients with Large Artery Atherosclerosis
por: Lee, Minwoo, et al.
Publicado: (2023)

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
por: Kühnast, Susan, et al.
Publicado: (2013)

Impact of chronic methamphetamine treatment on the atherosclerosis formation in ApoE−/− mice fed a high cholesterol diet
por: Zhu, Pengfei, et al.
Publicado: (2017)

Effect of Dietary Cholesterol and Cholesterol Oxides on Blood Cholesterol, Lipids, and the Development of Atherosclerosis in Rabbits
por: Hur, Sun Jin, et al.
Publicado: (2013)

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
por: Qian, Jing, et al.
Publicado: (2017)

Cumulative health deficits, APOE genotype, and risk for later-life mild cognitive impairment and dementia
por: Ward, David D, et al.
Publicado: (2021)

Ratio of apoB/LDL: a potential clinical index for vascular cognitive impairment
por: Qian, Cheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dteioev0jhsjcondg4me2vjsfm